Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 25 of 2548

TitleReference numberPublishedLast updated
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinomaTA1145
Suspected cancer: recognition and referralNG12
Menopause: identification and managementNG23
Ovarian cancerQS18
Transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistulaHTG777
Ovarian cancer: recognition and initial managementCG122
Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal)TA1144
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessmentHTG776
Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopauseTA1143
Fertility problems: assessment and treatmentNG257
Fertility problemsQS73
Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophilsTA1142
Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shockHTG774
Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shockHTG775
Fetal monitoring in labourNG229
Artificial intelligence (AI) technologies to help detect or characterise colorectal polypsHTG773
Kidney cancer: diagnosis and managementNG256
Kidney cancerQS215
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitationHTG772
Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overTA1140
Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer (terminated appraisal)TA1141
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessmentHTG746
Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatmentTA1139
Pegzilarginase for treating arginase-1 deficiency in people 2 years and overHST35
Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancerTA1138

Results per page

  1. 10
  2. 25
  3. 50
  4. All